Income Statement (2010. 7. 1. Spin off)

Home > investors > Hanmi Pharm > Financial Reports

Unit : 1 million won
Particulars 2011. 3Q 2010
Sales Revenue 383,849 294,304
Cost of Sales 196,199 140,486
Gross Profit 187,650 153,818
Selling general administrative expenses 135,548 -176,057
Research and Development Costs 43,607 -
Other Income 5,539 -
Other expenses 2,129 -
Operating Income(Loss) 11,905 -22,239
Finance income 2,088 -
Finance Cost 13,056 -
Profit (loss) before tax 937 -31,099
Income tax expense -395 -9,106
Profit (loss) 1,332 -21,993